Pharmacogenomics - how close/far are we to practising individualized medicine for children?
نویسندگان
چکیده
منابع مشابه
Pharmacogenetics, pharmacogenomics, and individualized medicine.
Individual variability in drug efficacy and drug safety is a major challenge in current clinical practice, drug development, and drug regulation. For more than 5 decades, studies of pharmacogenetics have provided ample examples of causal relations between genotypes and drug response to account for phenotypic variations of clinical importance in drug therapy. The convergence of pharmacogenetics ...
متن کاملNanorobots for medicine: how close are we?
Since the pioneering vision of Feynman in his now famous lecture ‘There’s Plenty of Room at the Bottom’ first delivered at an American Physical Society meeting at Caltech in December 1959 [1], film and scientific exploration at the nanoscale have been lending each other imagery and targets to achieve. It took only 5 years from Feynman’s lecture for a fellow resident of Los Angeles, Harry Kleine...
متن کاملSeventy FDG-PET/CT cases in which nuclear medicine physicians suspected lymphoma: How reliable are we?
Objective(s): To validate the reliability of nuclear medicine physicians in diagnosing lymphoma using positron emission tomography/computed tomography using 2-deoxy-2-[18F]fluoro-D-glucose (FDG-PET/CT) and to determine findings that reliably suggest lymphoma.Methods: Seventy patients suspected of having lymphoma using FDG-PET/CT were enrolled in this retrospective study. Two nuclear medicine ph...
متن کاملWhy aren't we practising homogenized medicine?
Why is the practice of intensive care so heterogenous? Uncertainty as to 'best practice', conservatism, and complacency may all contribute to our divergent management strategies. The need for further generalisable research, anonymised audit, external peer review and open access databases is discussed.
متن کاملPharmacogenomics and individualized drug therapy.
Pharmacogenetics deals with inherited differences in the response to drugs. The best-recognized examples are genetic polymorphisms of drug-metabolizing enzymes, which affect about 30% of all drugs. Loss of function of thiopurine S-methyltransferase (TPMT) results in severe and life-threatening hematopoietic toxicity if patients receive standard doses of mercaptopurine and azathioprine. Gene dup...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2015
ISSN: 0306-5251
DOI: 10.1111/bcp.12338